ASG Aurora Spine Corporation

First Surgical Implant of ZIP ULTRA(TM) MIS Interspinous Implant Performed in Poland

CARLSBAD, CALIFORNIA--(Marketwired - Mar 19, 2014) - Aurora Spine Corporation (TSX-VENTURE:ASG) announced today the first surgical implant of its ZIP ULTRA™ Minimally Invasive Interspinous Fusion Implant in Poland. The surgery was performed by Prof, Jacek Kaczmarczyk at the Ortopedyczno-Rehabilitacyjny Szpital Kliniczny nr 4w Poznaniu, Poznań, Polska.

"We are pleased to begin commercialization of the Aurora ZIP™ MIS Interspinous Fusion System in Poland and would like to thank Viktor DEGI MEDICAL UNIVERSITY for performing the procedure", said Trent J. Northcutt, President and CEO of Aurora Spine Corporation. "We passionately believe the ZIP MIS Interspinous Fusion Systems represents a significant opportunity to provide a better spinal fusion option for doctors, hospital systems and patients globally. The success of our screw-less spine procedure is a testament to our laser focus on disruptive technology and our commitment to - Simplifying the Complex".

This surgery is part of Aurora's continuing efforts to expand the use of its MIS device in Europe. Aurora's technology enables surgeons to expand patient selection, treat a wide range of spinal disorders and drive the shift toward minimally invasive techniques.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of Aurora Spine's products in surgical procedures. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Aurora Spine CorporationTrent NorthcuttPresident and Chief Executive Officer(760) 424-2004Aurora Spine CorporationEric FronkChief Financial Officer(760) 424-2004